Cerus (CERS) Amortization of Deferred Charges (2015 - 2026)
Cerus (CERS) reported Amortization of Deferred Charges of $98000.0 for Q1 2026, little changed on a YoY basis from $98000.0 in Q1 2025, and up 103.8% sequentially from -$2.6 million in Q4 2025.
Cerus (CERS) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
Cerus (CERS) has 12 years of Amortization of Deferred Charges data on file, last reported at $98000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $98000.0; the trailing twelve-month figure through Mar 2026 stood at -$469000.0 (down 121.68% YoY), and the FY2025 full-year result was $398000.0, changed 0.0% from the prior year.
- Amortization of Deferred Charges grew to $98000.0 in Q1 2026, from -$2.6 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $3.2 million in Q4 2023 to a low of -$2.6 million in Q4 2025.
- A 5-year average of $558294.1 and a median of $837000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges soared 2277.78% in 2023 and tumbled 2653.47% in 2025, its largest moves.
- Tracing CERS's Amortization of Deferred Charges over 5 years: stood at $135000.0 in 2022, then soared by 2277.78% to $3.2 million in 2023, then slumped by 96.85% to $101000.0 in 2024, then plunged by 2653.47% to -$2.6 million in 2025, then surged by 103.8% to $98000.0 in 2026.
- Business Quant data shows CERS's Amortization of Deferred Charges at $98000.0 in Q1 2026, -$2.6 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 176.78 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -2.58 Mn |
| Dec 31, 2025 | -2.58 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 98,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 101,000.00 |
| Dec 31, 2024 | 101,000.00 |
| Sep 30, 2024 | 964,000.00 |
| Sep 30, 2024 | 964,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 106,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 3.21 Mn |
| Dec 31, 2023 | 3.21 Mn |